Home - Products - Endocrinology/Hormones - AhR - AHR Inhibitor I-103

AHR Inhibitor I-103

CAS No. 2247951-12-6

AHR Inhibitor I-103( —— )

Catalog No. M37570 CAS No. 2247951-12-6

AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	296	Get Quote
5MG	459	Get Quote
10MG	657	Get Quote
25MG	994	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

AHR Inhibitor I-103
Note

Research use only, not for human use.
Brief Description

AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.
Description

AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Endocrinology/Hormones
Target

AhR
Recptor

AhR
Research Area

——
Indication

——

Chemical Information

CAS Number

2247951-12-6
Formula Weight

372.4
Molecular Formula

C21H17FN6
Purity

>98% (HPLC)
Solubility

——
SMILES

FC1=CN=CC(=C1)C2=NC3=CC=NN3C(=C2)NCCC4=CNC=5C=CC=CC54
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CH-223191

CH-223191 is a potent, specific antagonist of AhR (aryl hydrocarbon receptor), potently inhibits TCDD-induced AhR-dependent transcription with IC50 of 0.03 uM.
TCDD

A potent AHR (aryl hydrocarbon receptor) agonist that induces degradation of AhR by the ubiquitin-proteasome pathway.
WAY-605471

WAY-605471 is a AHR antagonist with IC50 of 0.5 - 1 μM.

Sign In Join Free